Sarah B. Klieger, Abraham Gutman, Leslie Allen, Rosalie Liccardo Pacula, Jennifer K. Ibrahim, Scott Burris
Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries
Addiction (21 July 2017)
Thomas C. Buchmueller, Colleen Carey
The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare
National Bureau of Economic Research (23 May 2017)
Daniel I. Rees, Joseph J. Sabia, Laura M. Argys, Joshua Latshaw, Dhaval Dave
With a Little Help from My Friends: The Effects of Naloxone Access and Good Samaritan Laws on Opioid-Related Deaths
National Bureau of Economic Research (17 February 2017)
Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
Addiction (8 February 2017)
Rosalie Liccardo Pacula
Testimony presented before the Florida House of Representatives Health & Human Services Committee, Subcommittee on Health Quality on January 25, 2017.
Regulatiing Medical Marijuana Markets (25 January 2017)
Stephen W. Patrick, Carrie E. Fry, Timothy F. Jones, Melinda B. Buntin
Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates.
Health Affairs (July 2016)
Lainie Rutkow, Hsien-Yen Chang, Matthew Daubresse, et al
Effect of Florida’s Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use
JAMA Internal Medicine (October 2015)
Traci C. Green, et al
Discrepancies in addressing overdose prevention through prescription monitoring programs.
Drug & Alcohol Dependence (August 2015)
Lainie Rutkow, Lydia Turner, Eleanor Lucas, Catherine Hwang, G. Caleb Alexander
Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access.
Health Affairs (March 2015)